Beam co-founder describes base editors with reduced RNA editing

TECHNIQUES CATEGORY: Drug platforms

TECHNOLOGY: Gene therapy

Beam Therapeutics co-founder J. Keith Joung and colleagues described

Read the full 142 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE